BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8750460)

  • 1. Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective.
    Beitz J; Gnecco C; Justice R
    J Natl Cancer Inst Monogr; 1996; (20):7-9. PubMed ID: 8750460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Starting and stopping cancer drugs: The need for randomized trials.
    Benjamin DJ; Prasad V
    J Cancer Policy; 2023 Dec; 38():100451. PubMed ID: 37918654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031.
    Meshinchi S; Hunger SP; Aplenc R; Adamson PC; Jessup JM
    Clin Cancer Res; 2012 Mar; 18(6):1547-54. PubMed ID: 22422407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions regarding the concept and definition of patient-reported outcomes among healthcare stakeholders in Japan with relation to quality of life: a cross-sectional study.
    Kaneyasu T; Saito S; Miyazaki K; Suzukamo Y; Naito M; Kawaguchi T; Nakajima TE; Yamaguchi T; Shimozuma K
    Health Qual Life Outcomes; 2024 Jan; 22(1):8. PubMed ID: 38243309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study (
    Maillard J; Elia N; Ris F; Courvoisier DS; Zekry D; Labidi Galy I; Toso C; Mönig S; Zaccaria I; Walder B
    BMJ Open; 2023 Feb; 13(2):e065902. PubMed ID: 36813502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients.
    Garnier L; Charton E; Falcoz A; Paget-Bailly S; Vernerey D; Jary M; Ducray F; Curtit E
    Neurooncol Pract; 2021 Apr; 8(2):148-159. PubMed ID: 33898048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving from clinician-defined to patient-reported outcome measures for survivors of high-grade glioma.
    Rosenlund L; Degsell E; Jakola AS
    Patient Relat Outcome Meas; 2019; 10():267-276. PubMed ID: 31692481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using PROMIS® to create clinically meaningful profiles of nephrotic syndrome patients.
    Troost JP; Gipson DS; Carlozzi NE; Reeve BB; Nachman PH; Gbadegesin R; Wang J; Modersitzki F; Massengill S; Mahan JD; Liu Y; Trachtman H; Herreshoff EG; DeWalt DA; Selewski DT
    Health Psychol; 2019 May; 38(5):410-421. PubMed ID: 31045424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer.
    Meyer L; Suidan R; Sun C; Westin S; Coleman RL; Mills GB
    Expert Rev Qual Life Cancer Care; 2016; 1(3):231-238. PubMed ID: 30906877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review.
    Ousmen A; Touraine C; Deliu N; Cottone F; Bonnetain F; Efficace F; Brédart A; Mollevi C; Anota A
    Health Qual Life Outcomes; 2018 Dec; 16(1):228. PubMed ID: 30537955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAR-T Cell Therapy: From the Bench to the Bedside.
    Golubovskaya V
    Cancers (Basel); 2017 Oct; 9(11):. PubMed ID: 29088081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events.
    Anwar S; Tan W; Hong CC; Admane S; Dozier A; Siedlecki F; Whitworth A; DiRaddo AM; DePaolo D; Jacob SM; Ma WW; Miller A; Adjei AA; Dy GK
    Cancers (Basel); 2017 Jun; 9(7):. PubMed ID: 28672850
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
    Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
    Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma.
    Paquette B; Vernerey D; Chauffert B; Dabakuyo S; Feuvret L; Taillandier L; Frappaz D; Taillia H; Schott R; Ducray F; Fabbro M; Tennevet I; Ghiringhelli F; Guillamo JS; Durando X; Castera D; Frenay M; Campello C; Dalban C; Skrzypski J; Chinot O; Anota A; Bonnetain F
    Cancer Med; 2016 Aug; 5(8):1753-64. PubMed ID: 27252150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review.
    Fiteni F; Anota A; Westeel V; Bonnetain F
    BMC Cancer; 2016 Feb; 16():122. PubMed ID: 26892541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307).
    Nuemi G; Devilliers H; Le Malicot K; Guimbaud R; Lepage C; Quantin C
    Health Qual Life Outcomes; 2015 Sep; 13():151. PubMed ID: 26391356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief review of recent Charcot-Marie-Tooth research and priorities.
    Ekins S; Litterman NK; Arnold RJ; Burgess RW; Freundlich JS; Gray SJ; Higgins JJ; Langley B; Willis DE; Notterpek L; Pleasure D; Sereda MW; Moore A
    F1000Res; 2015; 4():53. PubMed ID: 25901280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual and Reproductive Outcomes in Early Stage Cervical Cancer Patients after Excisional Cone as a Fertility-sparing Surgery: An Italian Experience.
    Fanfani F; Landoni F; Gagliardi ML; Fagotti A; Preti E; Moruzzi MC; Monterossi G; Scambia G
    J Reprod Infertil; 2014 Jan; 15(1):29-34. PubMed ID: 24696793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?
    Anota A; Hamidou Z; Paget-Bailly S; Chibaudel B; Bascoul-Mollevi C; Auquier P; Westeel V; Fiteni F; Borg C; Bonnetain F
    Qual Life Res; 2015 Jan; 24(1):5-18. PubMed ID: 24277234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of psychoeducational support on quality of life in early-stage breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.
    Matsuda A; Yamaoka K; Tango T; Matsuda T; Nishimoto H
    Qual Life Res; 2014 Feb; 23(1):21-30. PubMed ID: 23881515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.